search
Back to results

Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome (M&M's)

Primary Purpose

Marfan Syndrome

Status
Not yet recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Adapted Physical Activity program
Sponsored by
University Hospital, Toulouse
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Marfan Syndrome

Eligibility Criteria

7 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Genetically confirmed Marfan syndrome or related syndrome Girl or boy aged 7 to 17 Informed and written consent signed by at least one of the two holders of parental authority Patient affiliated to a social security scheme or equivalent Exclusion Criteria: Cardiac contraindications to the APA program: Severe aortic dilation (aortic diameter > 45 mm) and/or left ventricular failure (left ventricular ejection fraction <45%) and/or severe mitral leakage ≥ grade 3 Pregnancy

Sites / Locations

  • CHU Toulouse

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

6 month adapted physical activity

Arm Description

The various assessments will be carried out during 2 visits at 6 months interval as part of the usual follow-up at the Toulouse University Hospital. Standard cardiopulmonary exercise test assessment will be coupled with an assessment by an APA coach on the same day. The APA program built from the initial assessment will be returned to the child and his family during a videoconference. In addition, a regular reassessment and adjustment of this program will be made every 15 days during phone calls by the APA coach.

Outcomes

Primary Outcome Measures

Measurement of maximum endurance
maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured
Measurement of maximum endurance
maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured

Secondary Outcome Measures

Full Information

First Posted
March 31, 2023
Last Updated
April 20, 2023
Sponsor
University Hospital, Toulouse
search

1. Study Identification

Unique Protocol Identification Number
NCT05838235
Brief Title
Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome
Acronym
M&M's
Official Title
Marfan&Moves (M&M's) : an Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome: an Interventional, Prospective, Monocentric Study.
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
May 2023 (Anticipated)
Primary Completion Date
May 2024 (Anticipated)
Study Completion Date
November 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Toulouse

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This research study aims to evaluate the effect of a 6-month adapted physical activity program (APA) on the endurance capacities (evaluated as the maximum oxygen consumption [VO2 peak] on a cardiopulmonary exercise test) of children and adolescents with Marfan syndrome or related.
Detailed Description
Marfan syndrome (MFS) is characterized by the association of multisystem damage related to connective tissue fragility. The risk of aortic dissection has diverted attention from significant musculoskeletal damage despite commonly reported extreme fatigue and pain with impact on the patient's quality of life. In a recent study (Marfanpower, NCT03236571), investigators have observed reduced endurance capacities in children and teenagers with MFS (average VO2 peak at 60% of expected), which were significantly increased by an intensive rehabilitation program. Based on this experience, investigators aim to evaluate the effect of a physical activity program adapted to the daily life of the young patients on their endurance capacities and their quality of life. This program will be set up by an adapted physical activity (APA) coach after a complete assessment, including a cardiopulmonary exercise test with VO2 peak measurement, which will be carried out in the Reference Centre for Marfan syndrome at the Toulouse University Hospital. The VO2 peak evolution will be evaluated after 6 months of program. This is a recognized parameter for the evaluation of endurance and has been validated in children. Investigators hypothesize that the implementation of a physical activity program adapted to the daily life and interests of the child with MFS will efficiently improve endurance, prevent deconditioning and promote long term benefits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Marfan Syndrome

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
6 month adapted physical activity
Arm Type
Experimental
Arm Description
The various assessments will be carried out during 2 visits at 6 months interval as part of the usual follow-up at the Toulouse University Hospital. Standard cardiopulmonary exercise test assessment will be coupled with an assessment by an APA coach on the same day. The APA program built from the initial assessment will be returned to the child and his family during a videoconference. In addition, a regular reassessment and adjustment of this program will be made every 15 days during phone calls by the APA coach.
Intervention Type
Other
Intervention Name(s)
Adapted Physical Activity program
Intervention Description
The Adaptated Physical Activity program will consist of a Personalized Training Program
Primary Outcome Measure Information:
Title
Measurement of maximum endurance
Description
maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured
Time Frame
At baseline
Title
Measurement of maximum endurance
Description
maximum oxygen consumption (VO2 peak) during a cardiopulmonary exercise test will be measured
Time Frame
Up to 6 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Genetically confirmed Marfan syndrome or related syndrome Girl or boy aged 7 to 17 Informed and written consent signed by at least one of the two holders of parental authority Patient affiliated to a social security scheme or equivalent Exclusion Criteria: Cardiac contraindications to the APA program: Severe aortic dilation (aortic diameter > 45 mm) and/or left ventricular failure (left ventricular ejection fraction <45%) and/or severe mitral leakage ≥ grade 3 Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Thomas EDOUARD, MD
Phone
05 34 54 91 95
Email
edouard.t@chu-toulouse.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Fernanda BAJANCA
Email
bajanca.f@chu-toulouse.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas EDOUARD, MD
Organizational Affiliation
CHU Toulouse
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Toulouse
City
Toulouse
Country
France
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Thomas EDOUARD, MD

12. IPD Sharing Statement

Learn more about this trial

Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome

We'll reach out to this number within 24 hrs